Market Place
Sourcing Support
Feds: Impax struck `pay-for-delay` deal with Endo on Opana ER
01 Apr 2019 //
FIERCE PHARMA
Sandoz launches EpiPen rival at $250 per two-pack
18 Jan 2019 //
BIOPHARMA DIVE
Allergan architect Bisaro exits board as revamp continues
30 Aug 2018 //
FIERCE PHARMA
FTC imposes conditions on Amneal acquisition of Impax
11 Jul 2018 //
PHARMA LETTER
Novartis takes aim at EpiPen with deal for Adamis rival
02 Jul 2018 //
FIERCE PHARMA
Rytary® (Levodopa/Carbidopa) Capsules: Impax Lab, v. Actavis Laboratories
17 May 2018 //
PATENT LITIGATION
ANI Pharmaceuticals Completes Acq.of Generic Products & Assets from Amneal/Impax
07 May 2018 //
PR NEWSWIRE
U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs
01 May 2018 //
REUTERS
ANI Pharma`s Signs Agreements to Acquire Generic Products from Amneal/Impax
27 Apr 2018 //
PR NEWSWIRE
Mydayis®(Amphetamine ): Shire Development v. Impax Laboratories
13 Apr 2018 //
PATENT LITIGATION
Impax reaches $20 million deal to end trial over generic drug`s delay
30 Mar 2018 //
REUTERS
Impax settles retailers` antitrust cases over generic drug`s delay
26 Mar 2018 //
INVESTORS
Impax introduces generic Solodyn ER tablets
21 Feb 2018 //
PHARMABIZ
Impax Announces the Launch of an Authorized Generic Version of Solodyn®
20 Feb 2018 //
PR NEWSWIRE
Bisaro, Amneal poach top Allergan exec for CEO`s chair
19 Dec 2017 //
FIERCE PHARMA
Impax Labs shares rise on FDA approval of generic Renvela
23 Oct 2017 //
MARKETWATCH
Endo could be the next generics player hunting for M&A: analyst
04 Oct 2017 //
FIERCE PHARMA
Impax CEO Bisaro reportedly putting his M&A moves on Amneal
23 Sep 2017 //
FIERCE PHARMA
Impax Announces Settlement of Contract Litigation on Opana® ER Oxymorphone HCL
07 Aug 2017 //
PR NEWSWIRE
As drug prices drop, generics makers fight back with deals
28 Jul 2017 //
REUTERS
Impax Shares Jump on FDA Approval for Generic Version of Concerta
18 Jul 2017 //
THESTREET
Impax Announces FDA Approval of Generic Concerta Methylphenidate HCL
17 Jul 2017 //
PR NEWSWIRE
Rytary® (Levodopa/Carbidopa): Impax Laboratories, Inc. V. Actavis Laboratories
09 May 2017 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Impax Laboratories
10 Apr 2017 //
PATENT LITIGATION
Can ex-Actavis CEO Paul Bisaro work his growth magic at Impax?
27 Mar 2017 //
FIERCE PHARMA
Impax Labs weighs M&A options, figuring bigger is better in struggling generics
08 Mar 2017 //
FIERCE PHARMA
Mylan Generic EpiPen To Swipe Share From Impax, Kaleo: Analyst
28 Feb 2017 //
INVESTOR
Impax Confirms Patent Challenge Relating to Generic Aubagio Tablets
07 Jan 2017 //
PR NEWSWIRE
Impax Launches Generic Version of Kadian Extended Release Capsules
23 Dec 2016 //
PR NEWSWIRE
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
04 Nov 2016 //
BLOOMBERG
Generic Drug Makers Challenge FDA Plan to Withdraw their ADHD Pills
25 Oct 2016 //
STAT
Impax Launches Generic Version of Metadate CD- Extended-Release Capsules
22 Sep 2016 //
PR NEWSWIRE
Impax Launches Generic Version of Avodart® (Dutasteride) Capsules, 0.5 mg
24 Nov 2015 //
PR NEWS WIRE
Allergan Confirms Generic Rytary® Patent Challenge
22 Sep 2015 //
PR NEWS WIRE
Impax Receives FDA Approval for Generic Version of Testred® C-III
22 Sep 2015 //
PR NEWS WIRE
Actavis gets subpoena as DOJ probe of generic pricing moves up food chain
08 Aug 2015 //
FIERCE PHARMA
